Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Austria | de

Standort wählen

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Mexico | es
  • United States | en
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Venezuela | es
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Korea | ko
  • Australia | en
  • Bangladesh | en
  • Japan | ja
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Russia | ru
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Latvia | lv
  • Denmark | da
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Novartis Foundation | en
  • Sandoz | en
  • Global | en
  • South Africa | en
  • Turkey | tr
  • Egypt | en
  • Israel | he

Language & Country Selector for Mobile

language-selector-globe Austria

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Russia | ru
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Latvia | lv
  • Korea | ko
  • Australia | en
  • Denmark | da
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Egypt | en
  • Japan | ja
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Venezuela | es
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • 75 Jahre Arzneimittel aus Kundl/Schaftenau 
      • Forschung & Entwicklung 
      • Management 
      • Kontakt 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Patient*innen & Angehörige 
      • Patientenversprechen 
      • Patient Engagement & Advocacy 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
        • Broschüren 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Asciminib im Vergleich zu einem vom Prüfarzt ausgewählten Tyrosinkinase-Inhibitor (TKI) bei Patienten mit Philadelphia-Chromosom-positiver chronischer myeloischer Leukämie in der chronischen Phase (Ph+ CML-CP) CABL001J12301 
          • Studie zur Beurteilung der Wirksamkeit und Sicherheit von Alpelisib: CBYL719H12301 (EPIK-B3) 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
          • Studie zu neovaskulärer altersbedingter Makuladegeneration: CRTH258A2303 (TALON) 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      Patient*innen & Angehörige Patient*innen & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Fachkreise Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
        • Österreichische Initiativen 
        • Unser Fußabdruck 
        • Umwelt 
      • Ethik, Risiko und Compliance 
        • Code of Ethics 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
      A photo of people in a meeting hall Medien
    • Karriere 
      • Jobsuche 
      • Frauen bei Novartis 
      • So arbeiten wir 
      • Lernen & Weiterbildung 
      • Arbeiten bei Novartis Österreich 
      • Mitarbeitende 
      • Karriere-Programme 
      • Leistung & Vergütung 
      • Lehre 
      • Meet the teams 
      join-us-hero-image Karriere
    • Coronavirus 
      Transmission electron microscopic image of an isolate from a case of coronavirus disease (COVID-19) Coronavirus
    Homapage image Austria Startseite
  1. Home
  2. Career Search
  3. Career Search
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business
  • Functional Area
  • Date
Positionsbezeichnung Site Standort Division Business Functional Area Date
Elektriker/Elektrotechniker (m/w/d) Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Feb 03, 2023
Elektriker/Elektrotechniker (m/w/d) Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Feb 03, 2023
Elektriker/Elektrotechniker (m/w/d) Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Feb 03, 2023
Technical Transfer Lead Devices (m/f/d) Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development Feb 03, 2023
AS&T Specialist Schaftenau Austria Novartis Technical Operations QUALITY Quality Feb 03, 2023
Expert Engineering (m/f/d) Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development Feb 02, 2023
Maintenance Technician I - Mechanical (m/w/d) Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Feb 02, 2023
QC Analyst II (m/w/d) Schaftenau Austria Novartis Technical Operations QUALITY Quality Feb 01, 2023
Equipment Specialist (m/w/d) Kundl Austria Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Feb 01, 2023
BPA Manager (f/m/d) Kundl Austria Global Drug Development FINANCE GDD Audit & Finance Feb 01, 2023
Manufacturing Systems Lead Kundl Austria Novartis Technical Operations CONTRACT MANUFACTURING Information Technology Jan 31, 2023
Elektriker - Sterile Abfüllung (m/w/d) Schaftenau Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Jan 31, 2023
Equipment Operator (m/w/d) Kundl Austria Novartis Technical Operations CONTRACT MANUFACTURING Technical Operations Jan 31, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
QC Analyst I (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
Shift Lead I (m/w/d) Kundl Austria Novartis Technical Operations LARGE MOLECULES Technical Operations Jan 31, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 31, 2023
Senior Expert Scie.&Tech. – Analytical Characterization of Biopharma. Kundl Austria Global Drug Development TECHNICAL R & D GDD Research & Development Jan 30, 2023
QA Operations Specialist (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 30, 2023
Expert Science & Tech. – Analytical Characterization of Biopharma Kundl Austria Global Drug Development TECHNICAL R & D GDD Research & Development Jan 30, 2023
Produktionsmitarbeiter in der Penicillin Anlage (m/w/d) Kundl Austria Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Jan 30, 2023
QA Compliance Expert (f/m/d) Schaftenau Austria Novartis Technical Operations QUALITY Quality Jan 27, 2023
Shift Lead II Schaftenau Austria Novartis Technical Operations LARGE MOLECULES Technical Operations Jan 27, 2023
Senior QA Compliance Specialist (f/m/d) Schaftenau Austria Novartis Technical Operations QUALITY Quality Jan 27, 2023
P&O Services - Employment Taxes Partner Vienna Austria SANDOZ COMMERCIAL OPS EUROPE SZ Human Resources Jan 27, 2023
Sales Representative (f/m/d) Salzburg Kundl Austria PHARMA REGION EUROPE PHARMA Sales Jan 26, 2023
Sales Representative (f/m/d) Kärnten, Südtirol Vienna Austria PHARMA REGION EUROPE PHARMA Sales Jan 26, 2023
Sales Representative (f/m/d) Steiermark/Kärnten Vienna Austria ONCOLOGY ONCOLOGY BU Sales Jan 26, 2023
Sales Representative (f/m/d) Westen Kundl Austria ONCOLOGY ONCOLOGY BU Sales Jan 26, 2023
Key Account Manager RX Hospital Ost-Österreich (m/w/d) Vienna Austria SANDOZ COMMERCIAL OPS EUROPE SZ Sales Jan 26, 2023
Property Manager (m/w/d) Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Facilities & Administration Jan 26, 2023
Qualified Person (Biopharmaceutical Products) (f/m/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 25, 2023
Senior Manufacturing Controlling Manager (f/m/d) Kundl Austria Novartis Technical Operations NTO SANDOZ TECHOPS Audit & Finance Jan 25, 2023
ERC M&S Campus Business partner (f/m/d) Kundl Austria Novartis Technical Operations NTO LEGAL Legal & Intellectual Property & Compl. Jan 24, 2023
Mitarbeiter in der Penicillin – Produktion (m/w/d) Kundl Austria Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Jan 23, 2023
QC Analyst II (m/w/d) Kundl Austria Novartis Technical Operations QUALITY Quality Jan 23, 2023
Reliability Engineer Electrical (m/w/d) Schaftenau Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Jan 20, 2023
Validation Lead (f/m/d) Schaftenau Austria Novartis Technical Operations LARGE MOLECULES Technical Operations Jan 20, 2023
Reliability Engineer Metrology (m/w/d) Schaftenau Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Jan 20, 2023
Quality Lead – Medical Devices (f/m/d) Schaftenau Austria Global Drug Development QA GDD Quality Jan 19, 2023
Maintenance Planner (m/w/d) Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Jan 18, 2023
Indirect Tax Manager (f/m/d) Kundl Austria CTS FRA OPERATIONS NBS Audit & Finance Jan 18, 2023
QA Operations Expert (f/m/d) Schaftenau Austria Novartis Technical Operations QUALITY Quality Jan 18, 2023
C&Q Engineer Warehouse & Logistics Kundl Austria Novartis Technical Operations SITE DEVELOPMENT Technical Operations Jan 17, 2023
Senior Expert Engineering (80-100)* (f/m/d) – Packaging Technology Schaftenau Austria Global Drug Development TECHNICAL R & D GDD Research & Development Jan 16, 2023
RA CMC Associate Director (m/f/d), Schaftenau, Austria Schaftenau Austria Global Drug Development REG AFFAIRS GDD Research & Development Jan 16, 2023

Pagination

  • Page 1
  • Next page ››

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Patient*innen & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Sandoz Austria
  • Global site
Footer Bottom
© 2023 Novartis AG
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen weltweit.